Potassium channel blocker 4-aminopyridin
✍
Matthias Löhle; Wiebke Schrempf; Martin Wolz; Heinz Reichmann; Alexander Storch
📂
Article
📅
2008
🏛
John Wiley and Sons
🌐
English
⚖ 749 KB
## Abstract Episodic ataxia type 2 (EA2) is an autosomal‐dominant hereditary disorder clinically characterized by recurrent attacks of vertigo, imbalance and ataxia. Studies have shown that 4‐aminopyridine (4‐AP) is capable to prevent these attacks. However, there are no reports whether 4‐AP is abl